Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy

被引:0
|
作者
Dutra-Clarke, Marina [1 ]
Tapia, Daisy [2 ]
Curtin, Emily [2 ]
Ruenger, Dennis [1 ]
Lakatos, Anita [2 ]
Alandy-Dy, Zyza [2 ]
Freedkin, Linda [2 ]
Hall, Kathy [2 ]
Ercelen, Nesrin [2 ]
Alandy-Dy, Jousef [2 ]
Knight, Margaret [2 ]
Pahl, Madeline [2 ]
Lombardo, Dawn [2 ]
Kimonis, Virginia [2 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
关键词
D O I
10.1016/j.ymgme.2020.12.069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
63
引用
收藏
页码:S36 / S36
页数:1
相关论文
共 50 条
  • [21] Long term clinical outcomes in patients with Fabry disease receiving enzyme replacement therapy
    McKechnie, Douglas G. J.
    Mac Lochlainn, Dylan J.
    Mehta, Atul B.
    Hughes, Derralynn A.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S78 - S79
  • [22] Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
    Germain, Dominique P.
    Charrow, Joel
    Desnick, Robert J.
    Guffon, Nathalie
    Kempf, Judy
    Lachmann, Robin H.
    Lemay, Roberta
    Linthorst, Gabor E.
    Packman, Seymour
    Scott, C. Ronald
    Waldek, Stephen
    Warnock, David G.
    Weinreb, Neal J.
    Wilcox, William R.
    [J]. JOURNAL OF MEDICAL GENETICS, 2015, 52 (05) : 353 - 358
  • [23] Enzyme replacement therapy in Japanese Fabry disease patients.
    Eto, Y
    Ohashi, T
    Utsunomiya, Y
    Fujiwara, M
    Mizuno, A
    Inui, K
    Sakai, N
    Kitagawa, T
    Suzuki, Y
    Mochizuki, S
    Kawakami, M
    Hosoya, T
    Owada, M
    Sakuraba, H
    Saito, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 420 - 420
  • [24] Kidney transplantation and enzyme replacement therapy in patients with Fabry disease
    Cybulla, Markus
    Kurschat, Christine
    West, Michael
    Nicholls, Kathy
    Torras, Joan
    Sunder-Plassmann, Gere
    Feriozzi, Sandro
    [J]. JOURNAL OF NEPHROLOGY, 2013, 26 (04) : 645 - 651
  • [25] Clinical and laboratorial outcome of Brazilian Fabry patients on enzyme replacement therapy (ERT): Data from Brazilian Fabry Registry
    Martins, A. M.
    Gomes, J. G.
    Sobral, Neto J.
    Biagini, G.
    D'Almeida, L. O. D.
    Aranda, P. C.
    Sousa, A. F.
    Bastos, R., V
    Ura, S.
    Oliveira, R.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 134 - 134
  • [26] Fabry disease in children and response to enzyme replacement therapy: results from the fabry outcome survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Hartung, R.
    Kampmann, C.
    Beck, M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 122 - 122
  • [27] Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Kalkum, G.
    Kampmann, C.
    Beck, M.
    [J]. CLINICAL GENETICS, 2012, 81 (05) : 485 - 490
  • [28] Ambulatory enzyme replacement therapy and clinical evaluation in Fabry's disease
    Breunig, F
    Weidemann, F
    Strotmann, J
    Beer, M
    Krane, V
    Wanner, C
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 581 - 581
  • [29] Gastrointestinal manifestations of Fabry disease: Clinical response to enzyme replacement therapy
    Banikazemi, M
    Ullman, T
    Desnick, RJ
    [J]. MOLECULAR GENETICS AND METABOLISM, 2005, 85 (04) : 255 - 259
  • [30] Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
    Lenders, Malte
    Neusser, Leon Paul
    Rudnicki, Michael
    Nordbeck, Peter
    Canaan-Kuehl, Sima
    Nowak, Albina
    Cybulla, Markus
    Schmitz, Boris
    Lukas, Jan
    Wanner, Christoph
    Brand, Stefan-Martin
    Brand, Eva
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (12): : 2879 - 2889